{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:35:45Z","timestamp":1789792545508,"version":"4.0.1"},"reference-count":93,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":218,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["GCUGR1125681066D"],"award-info":[{"award-number":["GCUGR1125681066D"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2025,1,1]]},"DOI":"10.1016\/j.csbj.2025.08.007","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:11:29Z","timestamp":1754665889000},"page":"3625-3639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring novel furochochicine derivatives as promising JAK2 inhibitors in HeLa cells: Integrating docking, QSAR-ML, MD simulations, and experiments"],"prefix":"10.34133","volume":"27","author":[{"given":"Duangjai","family":"Todsaporn","sequence":"first","affiliation":[{"name":"Center of Excellence in Biocatalyst and Sustainable Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamonpan","family":"Sanachai","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanat","family":"Aonbangkhen","sequence":"additional","affiliation":[{"name":"Center of Excellence in Natural Products Chemistry (CENP), Department of Chemistry, Faculty of Science, Chulalongkorn University, Phayathai Road, Pathumwan, Bangkok 10330, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Geronikaki","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Kartsev","sequence":"additional","affiliation":[{"name":"InterBioscreen, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Lichitsky","sequence":"additional","affiliation":[{"name":"Zelinsky Institute of Organic Chemistry, Leninsky prospect, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Komogortsev","sequence":"additional","affiliation":[{"name":"Zelinsky Institute of Organic Chemistry, Leninsky prospect, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phornphimon","family":"Maitarad","sequence":"additional","affiliation":[{"name":"Research Center of Nano Science and Technology, Department of Chemistry, College of Science, Shanghai University, Shanghai 200444, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyada","family":"Rungrotmongkol","sequence":"additional","affiliation":[{"name":"Center of Excellence in Biocatalyst and Sustainable Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand"},{"name":"Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30482-6"},{"key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues","volume":"7","author":"Woodman C.B.","year":"2007","unstructured":"Woodman C.B., Collins S.I. and Young L.S.: The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007; 7: 11.","journal-title":"Nat Rev Cancer"},{"key":"e_1_3_5_4_2","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001540","article-title":"The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation","volume":"102","author":"Scarth J.A.","year":"2021","unstructured":"Scarth J.A. et al: The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation. J Gen Virol 2021; 102: 001540.","journal-title":"J Gen Virol"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32470-X"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1586\/17512433.2014.884924","article-title":"Advances in cervical cancer pharmacotherapies","volume":"7","author":"Markman M.","year":"2014","unstructured":"Markman M.: Advances in cervical cancer pharmacotherapies. Expert Rev Clin Pharmacol 2014; 7: 219.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31607-0"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201348"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071545"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00963"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1202117"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11122002"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1093-3","article-title":"Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2\/STAT3\/VEGFA signaling in non-small cell lung cancer cells","volume":"38","author":"Liang L.","year":"2019","unstructured":"Liang L. et al: Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2\/STAT3\/VEGFA signaling in non-small cell lung cancer cells. J Exp Clin Cancer Res 2019; 38: 1.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203575"},{"key":"e_1_3_5_15_2","first-page":"94","article-title":"Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo","volume":"6","author":"Kandala P.K.","year":"2012","unstructured":"Kandala P.K. and Srivastava S.K.: Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo. Drug Discov Ther 2012; 6: 94.","journal-title":"Drug Discov Ther"},{"key":"e_1_3_5_16_2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12935-022-02637-4","article-title":"LINC00893 inhibits the progression of prostate cancer through miR-3173-5p\/SOCS3\/JAK2\/STAT3 pathway","volume":"22","author":"Yu C.","year":"2022","unstructured":"Yu C. et al: LINC00893 inhibits the progression of prostate cancer through miR-3173-5p\/SOCS3\/JAK2\/STAT3 pathway. Cancer Cell Int 2022; 22: 228.","journal-title":"Cancer Cell Int"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3390\/cancers11121934","article-title":"JAK2 inhibition impairs proliferation and sensitises cervical cancer cells to cisplatin-induced cell death","volume":"11","author":"Morgan E.L.","year":"2019","unstructured":"Morgan E.L. and Macdonald A.: JAK2 inhibition impairs proliferation and sensitises cervical cancer cells to cisplatin-induced cell death. Cancers 2019; 11: 1934.","journal-title":"Cancers"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.08.011"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biopha.2016.05.029","article-title":"The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression","volume":"82","author":"Luo C.-l","year":"2016","unstructured":"Luo C.-l et al: The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression. Biomed Pharmacother 2016; 82: 595.","journal-title":"Biomed Pharmacother"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12090977"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c04769"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1039\/D0MD00436G","article-title":"Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives","volume":"12","author":"Sanachai K.","year":"2021","unstructured":"Sanachai K. et al: Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives. RSC Med Chem 2021; 12: 430.","journal-title":"RSC Med Chem"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.bmcl.2010.02.056","article-title":"Discovery and Sar of potent, orally available 2, 8-diaryl-quinoxalines as a new class of JAK2 inhibitors","volume":"20","author":"Pissot-Soldermann C.","year":"2010","unstructured":"Pissot-Soldermann C. et al: Discovery and Sar of potent, orally available 2, 8-diaryl-quinoxalines as a new class of JAK2 inhibitors. Bioorg Med Chem Lett 2010; 20: 2609.","journal-title":"Bioorg Med Chem Lett"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129308","article-title":"Discovery of furopyridine-based compounds as novel inhibitors of janus kinase 2: in silico and in vitro studies","author":"Suriya U.","year":"2024","unstructured":"Suriya U. et al: Discovery of furopyridine-based compounds as novel inhibitors of janus kinase 2: in silico and in vitro studies. Int J Biol Macromol 2024; : 129308.","journal-title":"Int J Biol Macromol"},{"key":"e_1_3_5_25_2","article-title":"Colchicine for acute gout","author":"McKenzie B.J.","year":"2021","unstructured":"McKenzie B.J. et al: Colchicine for acute gout. Cochrane Database Syst Rev 2021; .","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_26_2","volume-title":"Colchicine\u2014update on mechanisms of action and therapeutic usesSeminars in arthritis and rheumatism","author":"Leung Y.","year":"2015","unstructured":"Leung Y., Hui L. and Kraus V.: Colchicine\u2014update on mechanisms of action and therapeutic uses. Seminars in arthritis and rheumatism. : Elsevier Amsterdam 2015."},{"key":"e_1_3_5_27_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3899\/jrheum.130847","article-title":"Colchicine in behcet syndrome: a longterm survey of patients in a controlled trial","volume":"41","author":"Hamuryudan V.","year":"2014","unstructured":"Hamuryudan V. et al: Colchicine in behcet syndrome: a longterm survey of patients in a controlled trial. J Rheumatol 2014; 41: 735.","journal-title":"J Rheumatol"},{"key":"e_1_3_5_28_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2174\/1381612824666180116101823","article-title":"The role of colchicine in pericardial syndromes","volume":"24","author":"Lazaros G.","year":"2018","unstructured":"Lazaros G. et al: The role of colchicine in pericardial syndromes. Curr Pharm Des 2018; 24: 702.","journal-title":"Curr Pharm Des"},{"key":"e_1_3_5_29_2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10067-022-06402-w","article-title":"Efficacy and safety of colchicine for the treatment of osteoarthritis: a systematic review and meta-analysis of intervention trials","volume":"42","author":"Singh A.","year":"2023","unstructured":"Singh A. et al: Efficacy and safety of colchicine for the treatment of osteoarthritis: a systematic review and meta-analysis of intervention trials. Clin Rheumatol 2023; 42: 889.","journal-title":"Clin Rheumatol"},{"key":"e_1_3_5_30_2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/ATVBAHA.124.319851","article-title":"Colchicine\u2019s role in cardiovascular disease management","volume":"44","author":"Buckley L.F.","year":"2024","unstructured":"Buckley L.F. and Libby P.: Colchicine\u2019s role in cardiovascular disease management. Arterioscler Thromb Vasc Biol 2024; 44: 1031.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_5_31_2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000531313","article-title":"Beneficiary effects of colchicine on inflammation and fibrosis in a mouse model of kidney injury","volume":"147","author":"Landau D.","year":"2023","unstructured":"Landau D. et al: Beneficiary effects of colchicine on inflammation and fibrosis in a mouse model of kidney injury. Nephron 2023; 147: 693.","journal-title":"Nephron"},{"key":"e_1_3_5_32_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5114\/reum.2020.100088","article-title":"Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19","volume":"58","author":"Perricone C.","year":"2020","unstructured":"Perricone C., Bartoloni E. and Gerli R.: Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19. Reumatol\/Rheumatol 2020; 58: 261.","journal-title":"Reumatol\/Rheumatol"},{"key":"e_1_3_5_33_2","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1517\/17425255.2015.1076391","article-title":"Colchicine as an anti-inflammatory and cardioprotective agent","volume":"11","author":"Gasparyan A.Y.","year":"2015","unstructured":"Gasparyan A.Y. et al: Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin Drug Metab Toxicol 2015; 11: 1781.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00366-y"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15119","article-title":"Efficacy of the colchicine add-on therapy in patients with autoimmune chronic urticaria","volume":"34","author":"Nabavizadeh S.H.","year":"2021","unstructured":"Nabavizadeh S.H. et al: Efficacy of the colchicine add-on therapy in patients with autoimmune chronic urticaria. Dermatol Ther 2021; 34: e15119.","journal-title":"Dermatol Ther"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.21568"},{"key":"e_1_3_5_37_2","doi-asserted-by":"crossref","first-page":"1481595","DOI":"10.1155\/2023\/1481595","article-title":"Synthesis, antimicrobial, and anticancer activities of novel nitrofuran derivatives","volume":"2023","author":"Mohamed M.S.","year":"2023","unstructured":"Mohamed M.S. et al: Synthesis, antimicrobial, and anticancer activities of novel nitrofuran derivatives. J Chem 2023; 2023: 1481595.","journal-title":"J Chem"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2174\/1871520620666200424130204","article-title":"Synthesis, in vitro antitumor activity and molecular mechanism of novel furan derivatives and their precursors","volume":"20","author":"Lu D.","year":"2020","unstructured":"Lu D. et al: Synthesis, in vitro antitumor activity and molecular mechanism of novel furan derivatives and their precursors. AntiCancer Agents Med ChemAntiCancer Agents 2020; 20: 1475.","journal-title":"AntiCancer Agents Med ChemAntiCancer Agents"},{"key":"e_1_3_5_39_2","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.3390\/pharmaceutics14102104","article-title":"Sar study and molecular mechanism investigation of novel Naphthoquinone-furan-2-cyanoacryloyl hybrids with antitumor activity","volume":"14","author":"Liu P.","year":"2022","unstructured":"Liu P. et al: Sar study and molecular mechanism investigation of novel Naphthoquinone-furan-2-cyanoacryloyl hybrids with antitumor activity. Pharmaceutics 2022; 14: 2104.","journal-title":"Pharmaceutics"},{"key":"e_1_3_5_40_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137098","article-title":"Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: Sar and docking studies (2010 to till date)","volume":"1299","author":"Patel P.","year":"2024","unstructured":"Patel P. et al: Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: Sar and docking studies (2010 to till date). J Mol Struct 2024; 1299: 137098.","journal-title":"J Mol Struct"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2010.02.019"},{"key":"e_1_3_5_42_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103035","article-title":"Design, synthesis and anticervical cancer activity of new benzofuran\u2013pyrazol-hydrazono-thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents","volume":"89","author":"Abbas H.-A.S.","year":"2019","unstructured":"Abbas H.-A.S. and El-Karim S.S.Abd: Design, synthesis and anticervical cancer activity of new benzofuran\u2013pyrazol-hydrazono-thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents. Bioorg Chem 2019; 89: 103035.","journal-title":"Bioorg Chem"},{"key":"e_1_3_5_43_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/JIR.S262132","article-title":"Recent updates on anti-inflammatory and antimicrobial effects of furan natural derivatives","author":"Alizadeh M.","year":"2020","unstructured":"Alizadeh M. et al: Recent updates on anti-inflammatory and antimicrobial effects of furan natural derivatives. J Inflamm Res 2020; : 451.","journal-title":"J Inflamm Res"},{"key":"e_1_3_5_44_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129173","article-title":"Synthesis and biological evaluation of 2, 5-disubstituted furan derivatives containing 1, 3-thiazole moiety as potential \u03b1-glucosidase inhibitors","volume":"83","author":"He M.","year":"2023","unstructured":"He M. et al: Synthesis and biological evaluation of 2, 5-disubstituted furan derivatives containing 1, 3-thiazole moiety as potential \u03b1-glucosidase inhibitors. Bioorg Med Chem Lett 2023; 83: 129173.","journal-title":"Bioorg Med Chem Lett"},{"key":"e_1_3_5_45_2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0968-0896(01)00013-X","article-title":"Dicaffeoyl-or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors","volume":"9","author":"Hwang D.J.","year":"2001","unstructured":"Hwang D.J. et al: Dicaffeoyl-or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors. Bioorg Med Chem 2001; 9: 1429.","journal-title":"Bioorg Med Chem"},{"key":"e_1_3_5_46_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104958","article-title":"Design, synthesis and anti-influenza virus activity of furan-substituted spirothiazolidinones","volume":"112","author":"Apayd\u0131n \u00c7.B.","year":"2021","unstructured":"Apayd\u0131n \u00c7.B. et al: Design, synthesis and anti-influenza virus activity of furan-substituted spirothiazolidinones. Bioorg Chem 2021; 112: 104958.","journal-title":"Bioorg Chem"},{"key":"e_1_3_5_47_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/0074-02760140324","article-title":"The efficacy of 2-nitrovinylfuran derivatives against leishmania in vitro and in vivo","volume":"110","author":"Sifontes-Rodr\u00edguez S.","year":"2015","unstructured":"Sifontes-Rodr\u00edguez S. et al: The efficacy of 2-nitrovinylfuran derivatives against leishmania in vitro and in vivo. Mem\u00f3rias do Inst Oswaldo Cruz 2015; 110: 166.","journal-title":"Mem\u00f3rias do Inst Oswaldo Cruz"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.02.061"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2016.01.012"},{"key":"e_1_3_5_50_2","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","article-title":"Structure-based virtual screening for drug discovery: principles, applications and recent advances","volume":"14","author":"Lionta E.","year":"2014","unstructured":"Lionta E. et al: Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem 2014; 14: 1923.","journal-title":"Curr Top Med Chem"},{"key":"e_1_3_5_51_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13065-024-01165-8","article-title":"QSAR analysis of VEGFR-2 inhibitors based on machine learning, topomer CoMFA and molecule docking","volume":"18","author":"Ding H.","year":"2024","unstructured":"Ding H. et al: QSAR analysis of VEGFR-2 inhibitors based on machine learning, topomer CoMFA and molecule docking. BMC Chem 2024; 18: 59.","journal-title":"BMC Chem"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.3c01090"},{"key":"e_1_3_5_53_2","doi-asserted-by":"crossref","first-page":"31784","DOI":"10.1021\/acsomega.3c02799","article-title":"Machine Learning-Based approach to developing potent EGFR inhibitors for breast Cancer\u2500 design, synthesis, and in vitro evaluation","volume":"8","author":"Nada H.","year":"2023","unstructured":"Nada H. et al: Machine Learning-Based approach to developing potent EGFR inhibitors for breast Cancer\u2500 design, synthesis, and in vitro evaluation. ACS Omega 2023; 8: 31784.","journal-title":"ACS Omega"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.112.007336"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.01.041"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm276"},{"key":"e_1_3_5_57_2","doi-asserted-by":"crossref","unstructured":"Csizmadia P. MarvinSketch and MarvinView: molecule applets for the World Wide Web; 1999.","DOI":"10.3390\/ecsoc-3-01775"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv951"},{"key":"e_1_3_5_59_2","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3390\/molecules28073014","article-title":"Discovery of novel EGFR inhibitor targeting wild-type and mutant forms of EGFR: in silico and in vitro study","volume":"28","author":"Todsaporn D.","year":"2023","unstructured":"Todsaporn D. et al: Discovery of novel EGFR inhibitor targeting wild-type and mutant forms of EGFR: in silico and in vitro study. Molecules 2023; 28: 3014.","journal-title":"Molecules"},{"key":"e_1_3_5_60_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105787","article-title":"Structural dynamics and kinase inhibitory activity of three generations of tyrosine kinase inhibitors against wild-type, L858R\/T790M, and L858R\/T790M\/C797S forms of EGFR","volume":"147","author":"Todsaporn D.","year":"2022","unstructured":"Todsaporn D. et al: Structural dynamics and kinase inhibitory activity of three generations of tyrosine kinase inhibitors against wild-type, L858R\/T790M, and L858R\/T790M\/C797S forms of EGFR. Comput Biol Med 2022; 147: 105787.","journal-title":"Comput Biol Med"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0897"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020597"},{"key":"e_1_3_5_63_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-015-0109-z","article-title":"ChemDes: an integrated web-based platform for molecular descriptor and fingerprint computation","volume":"7","author":"Dong J.","year":"2015","unstructured":"Dong J. et al: ChemDes: an integrated web-based platform for molecular descriptor and fingerprint computation. J Chemin 2015; 7: 1.","journal-title":"J Chemin"},{"key":"e_1_3_5_64_2","volume-title":"An introduction to statistical learning: with applications in r","author":"Gareth J.","year":"2013","unstructured":"Gareth J. et al: An introduction to statistical learning: with applications in r. : Spinger 2013."},{"key":"e_1_3_5_65_2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-1353-0","volume-title":"Regression methods in biostatistics: linear, logistic, survival, and repeated measures models","author":"Vittinghoff E.","year":"2012","unstructured":"Vittinghoff E. et al: Regression methods in biostatistics: linear, logistic, survival, and repeated measures models. : Springer Science & Business Media 2012."},{"key":"e_1_3_5_66_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.sajce.2023.11.001","article-title":"Comparative analysis of preprocessing methods for molecular descriptors in predicting anti-cathepsin activity","volume":"47","author":"Suprapto S.","year":"2024","unstructured":"Suprapto S.: Comparative analysis of preprocessing methods for molecular descriptors in predicting anti-cathepsin activity. South Afr J Chem Eng 2024; 47: 123.","journal-title":"South Afr J Chem Eng"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1080\/00401706.1969.10490666"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2009.0222"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1021\/ct200909j"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.5b00255"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20035"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.445869"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.465608"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.448118"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1021\/ct400341p"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1021\/ct300418h"},{"key":"e_1_3_5_77_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2021.153292","article-title":"Straightforward One-step approach towards novel derivatives of 9-oxo-5, 6, 7, 9-tetrahydrobenzo [9, 10] heptaleno [3, 2-b] furan-12-yl) acetic acid based on the multicomponent reaction of colchiceine, arylglyoxals and Meldrum\u2019s acid","volume":"78","author":"Komogortsev A.N.","year":"2021","unstructured":"Komogortsev A.N., Lichitsky B.V. and Melekhina V.G.: Straightforward One-step approach towards novel derivatives of 9-oxo-5, 6, 7, 9-tetrahydrobenzo [9, 10] heptaleno [3, 2-b] furan-12-yl) acetic acid based on the multicomponent reaction of colchiceine, arylglyoxals and Meldrum\u2019s acid. Tetrahedron Lett 2021; 78: 153292.","journal-title":"Tetrahedron Lett"},{"key":"e_1_3_5_78_2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/s41598-023-49363-z","article-title":"Prediction of cell migration potential on human breast cancer cells treated with albizia lebbeck ethanolic extract using extreme machine learning","volume":"13","author":"Umar H.","year":"2023","unstructured":"Umar H., Aliyu M. and Usman A.: Prediction of cell migration potential on human breast cancer cells treated with albizia lebbeck ethanolic extract using extreme machine learning. 22242 Sci Rep 2023; 13: 2023.","journal-title":"Sci Rep"},{"key":"e_1_3_5_79_2","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.2174\/0109298673281684240102072157","article-title":"Discovery of Pyroptosis-inducing drugs and antineoplastic activity based on the ROS\/ER Stress\/Pyroptosis axis","volume":"31","author":"Gan X.","year":"2024","unstructured":"Gan X. et al: Discovery of Pyroptosis-inducing drugs and antineoplastic activity based on the ROS\/ER Stress\/Pyroptosis axis. Curr Med Chem 2024; 31: 4880.","journal-title":"Curr Med Chem"},{"key":"e_1_3_5_80_2","first-page":"1835","article-title":"Intracellular ATP levels determine cell death fate by apoptosis or necrosis","volume":"57","author":"Eguchi Y.","year":"1997","unstructured":"Eguchi Y., Shimizu S. and Tsujimoto Y.: Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997; 57: 1835.","journal-title":"Cancer Res"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867033368484"},{"key":"e_1_3_5_82_2","first-page":"1","article-title":"Molecular modeling of novel 2-aminopyridine derivatives as potential JAK2 inhibitors: a rational strategy for promising anticancer agents","author":"Munir N.","year":"2024","unstructured":"Munir N. et al: Molecular modeling of novel 2-aminopyridine derivatives as potential JAK2 inhibitors: a rational strategy for promising anticancer agents. J Biomol Struct Dyn 2024; : 1.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c04535"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.9b02800"},{"key":"e_1_3_5_85_2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3389\/fphar.2018.01379","article-title":"A novel selective JAK2 inhibitor identified using pharmacological interactions","author":"Lin T.E.","year":"2018","unstructured":"Lin T.E. et al: A novel selective JAK2 inhibitor identified using pharmacological interactions. Front Pharmacol 2018; : 1379.","journal-title":"Front Pharmacol"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0053"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111590"},{"key":"e_1_3_5_88_2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.bmc.2019.02.054","article-title":"Discovery of novel selective janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo [3, 4-d] pyrimidin-4-amino scaffold","volume":"27","author":"Yin Y.","year":"2019","unstructured":"Yin Y. et al: Discovery of novel selective janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo [3, 4-d] pyrimidin-4-amino scaffold. Bioorg Med Chem 2019; 27: 1562.","journal-title":"Bioorg Med Chem"},{"key":"e_1_3_5_89_2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/cbdd.13791","article-title":"Antimicrobial and antiproliferative activities of novel synthesized 6-(quinolin-2-ylthio) pyridine derivatives with molecular docking study as multi-targeted JAK2\/STAT3 inhibitors","volume":"97","author":"Nafie M.S.","year":"2021","unstructured":"Nafie M.S., Mahgoub S. and Amer A.M.: Antimicrobial and antiproliferative activities of novel synthesized 6-(quinolin-2-ylthio) pyridine derivatives with molecular docking study as multi-targeted JAK2\/STAT3 inhibitors. Chem Biol Drug Des 2021; 97: 553.","journal-title":"Chem Biol Drug Des"},{"key":"e_1_3_5_90_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113394","article-title":"Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2","volume":"218","author":"Xu P.","year":"2021","unstructured":"Xu P. et al: Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2. Eur J Med Chem 2021; 218: 113394.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.205"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep14538"},{"key":"e_1_3_5_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2015.07.008"},{"key":"e_1_3_5_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.03.013"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025003289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025003289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2025.08.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:35:01Z","timestamp":1775219701000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2025.08.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":93,"alternative-id":["10.1016\/j.csbj.2025.08.007"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2025.08.007","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring novel furochochicine derivatives as promising JAK2 inhibitors in HeLa cells: Integrating docking, QSAR-ML, MD simulations, and experiments","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2025.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}